Get started
Author

Julie Tomasina

Nanocarriers for the targeted treatment of ovarian cancers
2012 · Julie Tomasina, Stéphanie Lheureux, et al. · Biomaterials · 78
Rapid and soft formulation of folate-functionalized nanoparticles for the targeted delivery of tripentone in ovarian carcinoma
2013 · J. Tomasina, L. Poulain, et al. · International Journal of Pharmaceutics · 22
Transcriptional frameshifts contribute to protein allergenicity
2020 · Benoit Thouvenot, Olivier Roitel, et al. · Journal of Clinical Investigation · 6
Sensitization of ovarian carcinoma cells to Bcl-xL-targeting strategies through indirect modulation of Mcl-1 activity by MR22388, a molecule of the tripentone family
2013 · Julie Tomasina, Aurélie Malzert-Freon, et al. · Journal of Ovarian Research · 4
PDF
Origine moléculaire de l’allergie au lait de vache
2016 · J. Tomasina, M. Michel, et al. · Revue française d'allergologie · 1
Vectorisation nanoparticulaire d'agents cytotoxiques originaux en vue du traitement ciblé des tumeurs ovariennes
2012 · Julie Tomasina · 1
The Lipolysis-Stimulated Lipoprotein Receptor Contributes to Direct and Antibody-Enhanced SARS-CoV-2 Pathogenicity
2023 · Florian Pierre, Hélène Jeulin, et al. · SSRN Electronic Journal
Infidélité de la transcription et origine de l’allergie
2017 · B. Thouvenot, B. Hilselberger, et al. · Revue française d'allergologie
Abstract 5287: RNA DNA divergences: An unsuspected marker of cancer genomic instability accurately predicts triple-negative breast cancer severity
2015 · Bernard E. Bihain, Stéphane Verdun, et al. · Cancer Research
Clinical utility of in depth RNA sequencing for non-metastatic triple negative breast cancers.
2015 · Benoit Thouvenot, Stephane Verdun, et al. · Journal of Clinical Oncology
P272 Using next-generation sequencing to predict clinical outcome of triple negative breast cancer
2015 · B. Thouvenot, S. Verdun, et al. · The Breast
Works count: 12
Citation count: 112
H-index: 4
I10-index: 2
Year
Topic
Type